SCHEMBL4347116

SCHEMBL4347116

Oc1c(Cl)cc(Cl)cc1NCc1ccccc1Sc1ccc2cccnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
MEN1 O00255 10/20 0.40
KMT2A Q03164 10/20 0.40
GFER P55789 2/20 0.40
CASP6 P55212 1/20 0.39
CTSD P07339 3/20 0.38
MAPT P10636 4/20 0.37
KDM4E B2RXH2 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 3/20 0.37
BLM P54132 2/20 0.37
NSD2 O96028 1/20 0.37
NR4A2 P43354 1/20 0.37
HPGD P15428 3/20 0.35
POLB P06746 3/20 0.35
LMNA P02545 2/20 0.35
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
APAF1 O14727 1/20 0.34
PTBP1 P26599 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4344502 0.90 MEN1 (0.43) GAAMEN1KMT2ACASP6MAPT
SCHEMBL6225665 0.89 MEN1 (0.38) GAAMEN1KMT2AGFERCASP6
SCHEMBL4347953 0.87 KMT2A (0.35) GAAMEN1KMT2AGFERCASP6
SCHEMBL4350092 0.87 CTSD (0.38) GAAMEN1KMT2ACASP6CTSD
SCHEMBL4347133 0.87 KMT2A (0.51) GAAMEN1KMT2ACASP6MAPT
SCHEMBL4347648 0.87 GAA (0.38) GAAMEN1KMT2AGFERCASP6
SCHEMBL4359469 0.86 KMT2A (0.35) GAAMEN1KMT2ACASP6MAPT
SCHEMBL4352845 0.84 MEN1 (0.34) GAAMEN1KMT2ACASP6MAPT
SCHEMBL4354659 0.83 KDM4E (0.40) GAAMEN1KMT2ACASP6MAPT
SCHEMBL4347776 0.83 KMT2A (0.44) GAAMEN1KMT2ACASP6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 GAA 4010/4885MEN1 2168/4885KMT2A 2096/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 GAA 3384/4885MEN1 3901/4885KMT2A 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.